Business Description
Vectorite Biomedical Inc
ISIN : TW0004170006
Total Employee Number:
50Description
Vectorite Biomedical Inc is a Taiwan-based biotechnology research and development, cell product (preparation) manufacturing and immune cell collection and storage business.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 443.14 | |||||
Equity-to-Asset | 0.95 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 14.6 | |||||
Beneish M-Score | -0.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.5 | |||||
3-Year Book Growth Rate | 21.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.08 | |||||
9-Day RSI | 52.93 | |||||
14-Day RSI | 47.96 | |||||
3-1 Month Momentum % | -9.42 | |||||
6-1 Month Momentum % | -8.09 | |||||
12-1 Month Momentum % | 2.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.85 | |||||
Quick Ratio | 10.93 | |||||
Cash Ratio | 10.54 | |||||
Days Inventory | 143.8 | |||||
Days Sales Outstanding | 34.65 | |||||
Days Payable | 10.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 15.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.31 | |||||
Operating Margin % | -35.68 | |||||
Net Margin % | 156.62 | |||||
EBITDA Margin % | 169.84 | |||||
FCF Margin % | -15.93 | |||||
OCF Margin % | -9.42 | |||||
ROE % | 22.77 | |||||
ROA % | 21.54 | |||||
ROIC % | -8.45 | |||||
3-Year ROIIC % | 10.11 | |||||
ROC (Joel Greenblatt) % | 53.02 | |||||
ROCE % | 22.31 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5.71 | |||||
PE Ratio without NRI | 5.71 | |||||
Price-to-Owner-Earnings | 5.2 | |||||
PS Ratio | 8.94 | |||||
PB Ratio | 1.13 | |||||
Price-to-Tangible-Book | 1.13 | |||||
EV-to-EBIT | 3.88 | |||||
EV-to-EBITDA | 3.58 | |||||
EV-to-Revenue | 6.07 | |||||
EV-to-FCF | -38.12 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Median-PS-Value | 0.49 | |||||
Price-to-Graham-Number | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 3.27 | |||||
| Price-to-Net-Cash | 3.75 | |||||
Earnings Yield (Greenblatt) % | 25.77 | |||||
FCF Yield % | -1.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vectorite Biomedical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 61.406 | ||
| EPS (TTM) (NT$) | 2.19 | ||
| Beta | -0.0477 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.46 | ||
| Volatility % | 30.25 | ||
| 14-Day RSI | 47.96 | ||
| 14-Day ATR (NT$) | 0.499956 | ||
| 20-Day SMA (NT$) | 12.4125 | ||
| 12-1 Month Momentum % | 2.88 | ||
| 52-Week Range (NT$) | 11.45 - 18.15 | ||
| Shares Outstanding (Mil) | 43.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vectorite Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vectorite Biomedical Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.10057:1 Stock Split | 2015-08-27 | 17.76 (+0.00%) |
Show
Entries
Vectorite Biomedical Inc Frequently Asked Questions
What is Vectorite Biomedical Inc(ROCO:4170)'s stock price today?
The current price of ROCO:4170 is NT$12.50. The 52 week high of ROCO:4170 is NT$18.15 and 52 week low is NT$11.45.
When is next earnings date of Vectorite Biomedical Inc(ROCO:4170)?
The next earnings date of Vectorite Biomedical Inc(ROCO:4170) is .
Does Vectorite Biomedical Inc(ROCO:4170) pay dividends? If so, how much?
Vectorite Biomedical Inc(ROCO:4170) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vectorite Biomedical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers